Table 1.
Characteristics | n | % |
---|---|---|
| ||
Total number | 331 | 100 |
Gender | ||
Male | 219 | 66.2 |
Female | 112 | 33.8 |
Age (years) | ||
<45 | 263 | 79.5 |
≥45 | 68 | 20.5 |
Median | 35 | |
Range | 30–42 | |
Ethnicity | ||
Thai | 297 | 89.7 |
Non-Thai$ | 34 | 10.3 |
Marital status | ||
Married | 146 | 44.5 |
Single | 87 | 26.5 |
Widowed/divorced | 95 | 29.0 |
Education | ||
Uneducated | 24 | 10.2 |
Primary | 150 | 63.8 |
Secondary | 55 | 23.4 |
Higher than secondary | 6 | 2.6 |
Occupation | ||
Casual laborer | 140 | 43.8 |
Farmer | 84 | 26.3 |
Household worker | 36 | 11.3 |
Prisoner | 16 | 5.0 |
Business owner | 13 | 4.1 |
Government employee | 6 | 1.9 |
Other | 6 | 1.9 |
Unemployed | 19 | 5.9 |
TB-related information | ||
Site of TB | ||
Pulmonary TB | 134 | 40.5 |
Extrapulmonary with pulmonary TB | 64 | 19.3 |
Extrapulmonary TB | 133 | 40.2 |
Location/type of extrapulmonary TB | 197 | |
Meningeal | 60 | 30.5 |
Lymphatic | 41 | 20.8 |
Intestinal | 38 | 19.3 |
Disseminated | 36 | 18.3 |
Pleural | 12 | 6.1 |
Bone | 4 | 2.0 |
Liver | 4 | 2.0 |
Pericardial | 1 | 0.5 |
Cutaneous | 1 | 0.5 |
TB treatment regimen | ||
CAT-1 regimen | 301 | 91.0 |
Non-CAT-1 regimens | 30 | 9.0 |
Tuberculosis diagnosis reconfirmation* | ||
Definite | 102 | 30.8 |
Probable | 46 | 13.9 |
Presumptive | 165 | 49.9 |
NTM | 18 | 5.4 |
MDR TB | ||
Yes | 7 | 2.1 |
No | 324 | 97.9 |
HIV-related information | ||
Time of HIV diagnosis | ||
Known before TB treatment | 219 | 66.2 |
Not known before TB treatment | 112 | 33.8 |
CD4 count (cells/mm3) | ||
CD4 count < 200 | 205 | 61.93 |
CD4 count ≥ 200 | 23 | 6.95 |
Unknown | 103 | 31.12 |
Median CD4 count | 37 | |
Range | 14–124 | |
ART status | ||
Received after TB diagnosis | 35 | 10.6 |
Received before TB diagnosis | 73 | 22.1 |
Not received | 223 | 67.4 |
ART regimen (last regimen during TB treatment) | 108 | |
NVP base | 77 | 71.3 |
EFV base | 24 | 22.2 |
PI base | 4 | 3.7 |
Other | 1 | 1.0 |
Unknown | 2 | 1.8 |
Preventive cotrimoxazole therapy | ||
Yes | 224 | 67.7 |
No | 107 | 32.3 |
Preventive fluconazole therapy | ||
Yes | 175 | 52.9 |
No | 156 | 47.1 |
Time of death after start of TB treatment | ||
Within 30 days | 121 | 36.56 |
Later than 30 days | 210 | 63.44 |
Notes: Definitive: evidence for TB diagnosis from both positive smear for acid-fast bacilli and culture growth for Mycobacterium tuberculosis. Probable: evidence for TB diagnosis from positive smear for acid-fast bacilli but no culture confirmation. Presumptive: neither smear acid-fast bacilli positive nor culture confirmation.
TB diagnosis was reconfirmed by two physicians;
Non-Thai means migrants from Laos and Myanmar and hill tribes.
Abbreviations: ART, antiretroviral therapy; NTM, nontuberculous mycobacterium; MDR TB, multidrug resistant tuberculosis; TAD, treatment after default; EFV, efavirenz; NVP, nevirapine; PI, protease inhibitor; HIV, human immunodeficiency virus; CAT-1, World Health Organization standard category 1 TB treatment regimen (2HRZE/4HR).